| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 09/17/2013 | US8536194 Pyrazolopyridine derivates |
| 09/17/2013 | US8536193 Inhibitors of AKT activity |
| 09/17/2013 | US8536192 6,7-unsaturated-7-carbamoyl substituted morphinan derivative |
| 09/17/2013 | US8536191 Crystalline and amorphous forms of nalbuphine hydrochloride |
| 09/17/2013 | US8536190 Treating unwanted ocular conditions using an ascomycin macrolactam |
| 09/17/2013 | US8536189 Spiropiperidines for use as tryptase inhibitors |
| 09/17/2013 | US8536187 2,4,6-trisubstituted pyrido(3,2-d)pyrimidines useful for treating viral infections |
| 09/17/2013 | US8536185 Multiheteroaryl compounds as inhibitors of H-PGDS and their use for treating prostaglandin D2 mediated diseases |
| 09/17/2013 | US8536184 Nitrogenous heterocyclic compounds and process for making nitrogenous heterocyclic compounds and intermediates thereof |
| 09/17/2013 | US8536183 3-pyridylcarbonyl-piperazinylsulfonyl derivatives |
| 09/17/2013 | US8536182 Benzylpiperazine derivatives and their medical use |
| 09/17/2013 | US8536181 Prolyl hydroxylase inhibitors |
| 09/17/2013 | US8536180 Pyrimidine inhibitors of kinase activity |
| 09/17/2013 | US8536179 Indoles |
| 09/17/2013 | US8536178 Pharmaceutical composition for preventing or treating diseases associated with beta-amyloid accumulation containing morpholin or piperazine based compounds having SO3H or COOH as active ingredient |
| 09/17/2013 | US8536177 Therapeutic agents useful for treating pain |
| 09/17/2013 | US8536176 GPR119 agonist |
| 09/17/2013 | US8536175 Quinoxaline carboxamide derivatives as protein tyrosine kinase inhibitors |
| 09/17/2013 | US8536174 Urotensin II receptor antagonists |
| 09/17/2013 | US8536173 Tetrahydroquinoxaline urea derivatives as modulators of 11-B-hydroxysteroid dehydrogenase type I |
| 09/17/2013 | US8536172 Inhibitors of JNK |
| 09/17/2013 | US8536171 Method for obtaining 5-amino 2,3-dihydrophthalazine-1,4-dione alkali metal salts and their use in medicine |
| 09/17/2013 | US8536170 Curable composition comprising a di-isoimide, method of curing, and the cured composition so formed |
| 09/17/2013 | US8536169 Compounds |
| 09/17/2013 | US8536168 Benzyl and pyridinyl derivatives as modulators of the hedgehog signaling pathway |
| 09/17/2013 | US8536167 Methods for treating ophthalmic, otic, or nasal infections |
| 09/17/2013 | US8536166 Inhibitors of Burton's tyrosine kinase |
| 09/17/2013 | US8536165 Azabiphenylaminobenzoic acid derivatives as DHODH inhibitors |
| 09/17/2013 | US8536164 Fused pyridine compounds as casein kinase inhibitors |
| 09/17/2013 | US8536163 Therapeutic compositions |
| 09/17/2013 | US8536162 Conjugates of 1,4,7-triazacyclononanes, dinuclear metal complexes of such conjugates, and methods of use for both 1,4,7-triazacyclononanes and conjugates |
| 09/17/2013 | US8536161 Combinations of phosphoinositide 3-kinase inhibitor compounds and chemotherapeutic agents for the treatment of hematopoietic malignancies |
| 09/17/2013 | US8536160 Azaheterocyclyl derivatives of androstanes and androstenes as medicaments for cardiovascular disorders |
| 09/17/2013 | US8536159 Organic compounds |
| 09/17/2013 | US8536158 Compounds having CRTH2 antagonist activity |
| 09/17/2013 | US8536157 Non-steroidal compounds |
| 09/17/2013 | US8536156 Contraception process and administration form for the same |
| 09/17/2013 | US8536155 Process for preparing malathion for pharmaceutical use |
| 09/17/2013 | US8536153 Chemical synthesis of phosphatidylinositol mannoside glycans from Mycobacterium tuberculosis |
| 09/17/2013 | US8536152 Methods of using diacerein as an adjunctive therapy for diabetes |
| 09/17/2013 | US8536151 Process for preparing lamivudine polymorph form |
| 09/17/2013 | US8536150 Methods of myocardial perfusion imaging |
| 09/17/2013 | US8536149 TRPM-2 antisense therapy |
| 09/17/2013 | US8536147 Antibacterial antisense oligonucleotide and method |
| 09/17/2013 | US8536144 Anti-fungal composition |
| 09/17/2013 | US8536143 Compositions to treat bacterial and inflammatory affections in pet animals dosage form and method to treat pet animals |
| 09/17/2013 | US8536142 Spinosyns for wound healing |
| 09/17/2013 | US8536141 Polyacetylenic compounds for protecting against pancreatic islet atrophy |
| 09/17/2013 | US8536140 Methods for treating inflammatory bowel disease |
| 09/17/2013 | US8536139 Compositions comprising lipoteichoic acid for use in treating pleural effusion or pneumothorax |
| 09/17/2013 | US8536138 Treatment of pulmonary hypertension with carbonic anhydrase inhibitors |
| 09/17/2013 | US8536134 Mixture of Cyclosporin A, oil and surfactant |
| 09/17/2013 | US8536133 Selective high-affinity polydentate ligands and methods of making such |
| 09/17/2013 | US8536130 Use of 1 phenyl-3-dimethylamino-propane compounds for treating neuropathic pain |
| 09/17/2013 | US8536120 Ghrelin/growth hormone releasing peptide/growth hormone secretatogue receptor antagonists and uses thereof |
| 09/17/2013 | US8535899 Assay for identifying a modulator of HIF hydroxylase |
| 09/17/2013 | US8535725 Porous-wall hollow glass microspheres as carriers for biomolecules |
| 09/17/2013 | US8535721 Pharmaceutical microspheres containing valproic acid for oral administration |
| 09/17/2013 | US8535718 Dosage forms of bisphosphonates |
| 09/17/2013 | US8535717 Pharmaceutical composition |
| 09/17/2013 | US8535716 Methods and composition of extended delivery of water insoluble drugs |
| 09/17/2013 | US8535715 Bilayer tablet formulations |
| 09/17/2013 | US8535714 Small volume oral transmucosal dosage forms containing sufentanil for treatment of pain |
| 09/17/2013 | US8535697 Cosmetic composition |
| 09/17/2013 | US8535696 Treating eczema and/or psoriasis |
| 09/17/2013 | US8535689 Identification of bacterial autoinducer and use in treating bacterial pathogenicity |
| 09/17/2013 | US8535670 Method of treating colorectal cancer tumor |
| 09/17/2013 | US8535660 Nutritional supplements for pregnant women |
| 09/17/2013 | US8535659 Nutritional supplements for pregnant women |
| 09/17/2013 | US8535658 Antitumor vaccination using allogeneic tumor cells expressing alpha (1,3)-galactosyltransferase |
| 09/17/2013 | US8535656 Amphiphilic polymer-protein conjugates and methods of use thereof |
| 09/17/2013 | US8535655 Biodegradable polymer—bioactive moiety conjugates |
| 09/17/2013 | US8535650 Stabilized reverse micelle compositions and uses thereof |
| 09/17/2013 | US8535647 Cosmetic/sunscreen compositions containing dibenzoylmethane compounds and dithiolane compound photostabilizers therefor |
| 09/17/2013 | US8535646 Method of inhibiting harmful microorganisms and barrier-forming composition therefor |
| 09/17/2013 | CA2810477C Oral drug delivery system |
| 09/17/2013 | CA2775616C Salts of benzimidazole compound and application thereof |
| 09/17/2013 | CA2740471C Morpholinopurine derivatives |
| 09/17/2013 | CA2732101C Aurora kinase modulators and methods of use |
| 09/17/2013 | CA2722418C Fused nitrogen containing heterocycles and compositions thereof as kinase inhibitors |
| 09/17/2013 | CA2694209C Azepine derivatives as gamma-secretase inhibitors |
| 09/17/2013 | CA2694136C Pi3 kinase modulators and methods of use |
| 09/17/2013 | CA2686382C Phenylaminopyrimidine derivatives and compositions thereof as c-kit and pdgfr kinase inhibitors |
| 09/17/2013 | CA2669503C Compounds and methods for thiol-containing compound efflux and cancer treatment |
| 09/17/2013 | CA2649043C Azolecarboxamide derivative |
| 09/17/2013 | CA2632626E Ester prodrugs of 2'-fluoro-2'-alkyl-2'-deoxycytidines and their use in the treatment of hcv infection |
| 09/17/2013 | CA2610475C Derivative prodrugs of ethinyl estradiol |
| 09/17/2013 | CA2607280C Benzimidazole-carboxamide compounds as 5-ht4 receptor agonists |
| 09/17/2013 | CA2606583C Aldehyde conjugated flavonoid preparations |
| 09/17/2013 | CA2606081C Combination of the application of antibodies for immunostimulation together with glucocorticoids |
| 09/17/2013 | CA2604943C Pharmaceutical delivery systems for hydrophobic drugs and compositions comprising same |
| 09/17/2013 | CA2604562C Use of a benzoyl derivative of 3-aminocarbazole for the treatment of a disorder associated with the production of prostaglandin e2 (pge2) |
| 09/17/2013 | CA2604193C A process for the purification of 10-deacetylbaccatine iii from 10-deacetyl-2- debenzoyl-2-pentenoylbaccatine iii |
| 09/17/2013 | CA2591673C Compositions comprising extracts from sanguinaria or macleaya |
| 09/17/2013 | CA2574088C Oligonucleotides comprising a modified or non-natural nucleobase |
| 09/17/2013 | CA2570903C N-hydroxyamide derivatives and use thereof |
| 09/17/2013 | CA2562711C Cab molecules |
| 09/17/2013 | CA2562685C Single-stranded and double-stranded oligonucleotides comprising a 2-arylpropyl moiety |
| 09/17/2013 | CA2562614C Use of treprostinil to treat neuropathic diabetic foot ulcers |
| 09/17/2013 | CA2554486C Treatment of bacterial infections |